Update in diagnosis and management of interstitial lung disease-Reference-Cited by-同舟云学术

Update in diagnosis and management of interstitial lung disease

Published:2016-12 Issue:Suppl 6 Volume:16 Page:s71-s78
ISSN:1470-2118
Container-title:Clinical Medicine
language:en
Short-container-title:Clin Med

Author:

Mikolasch Theresia A,Garthwaite Helen S,Porter Joanna C

Publisher

Royal College of Physicians

Subject

General Medicine

Reference28 articles.

1. British Lung Foundation . Lung disease in the UK – big picture statistics. https://statistics.blf.org.uk/lung-disease-uk-big-picture [Accessed 19 October 2016].

2. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

3. Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

4. Cyclophosphamide versus Placebo in Scleroderma Lung Disease

5. Rituximab in severe, treatment-refractory interstitial lung disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge, attitude, and practice toward interstitial lung disease among patients: a cross-sectional study;Frontiers in Medicine;2024-06-20

2. Just the facts: approach to the patient with Interstitial Lung Disease (ILD) in the emergency department;Canadian Journal of Emergency Medicine;2024-05-08

3. Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment – Evidence in disease-relevant in-vitro models;Journal of Drug Delivery Science and Technology;2024-05

4. Investigating the role of platelets and platelet-derived transforming growth factor-β in idiopathic pulmonary fibrosis;American Journal of Physiology-Lung Cellular and Molecular Physiology;2023-10-01

5. Interstitial Lung Disease: A Focused Review for the Emergency Clinician;The Journal of Emergency Medicine;2023-02